Ultracet Indications/Uses

Adults: ULTRACET (tramadol hydrochloride and paracetamol) is indicated for the management of moderate to moderately severe pain.
ULTRACET has not been systematically evaluated beyond 12 weeks in controlled clinical trials. Therefore, the physician who elects to use ULTRACET for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
Geriatrics (> 65 years of age): In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, concomitant disease or other drug therapy.
Healthy elderly subjects aged 65 to 75 years administered tramadol have plasma concentrations and elimination half-lives comparable to those observed in healthy subjects less than 65 years of age. ULTRACET should be administered with greater caution in patients older than 75 years, due to the greater potential for adverse events in this population (see Precautions and Dosage & Administration).
Pediatrics (<18 years of age): The safety and efficacy of ULTRACET has not been studied in the pediatric population. Therefore, use of ULTRACET is not recommended in patients under 18 years of age.